Philip Morris International Inc. (PMI) announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction. “The acquisition of OtiTopic is an exciting step in PMI’s Beyond Nicotine ambitions,” said Jacek Olczak, CEO, PMI. “We have world-class expertise in the research, development, and […]
Tag: Jorge Insuasty
Philip Morris International Inc. (PMI) announced it has agreed with the board of Vectura Group plc (Vectura) on the terms of an all-cash, recommended offer to acquire Vectura for an enterprise value of GBP 852 million (approximately USD 1.2 billion). Under the terms of the acquisition, Vectura shareholders would be entitled to receive 150 pence […]